MAP3K8 and cancer: Although MAP3K8 was originally recognized as an oncogene since its discovery in 1991 (Miyoshi et al., 1991), genetic sequence analyses identified rare MAP3K8 mutations which is much less than altered expression and abnormal activation in human cancers.